ANALIA GRAY: Open Payments
NPI 1699023168 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 6 payments from 4 companies in 2025. Trend: 2023 $58 · 2024 $284 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $227 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $82 |
| Viatris Specialty LLC | 1 | $18 |
Products named: INGREZZA, REXULTI, NUPLAZID, YUPELRI.
Industry payments across CT — which companies pay providers there.
